Close Menu

NEW YORK – Aspira Women's Health said Thursday that is has entered a collaborative research agreement with Baylor Genetics to codevelop an early detection test for ovarian cancer.

Austin, Texas-based Aspira said it will bring its experience in recruitment of patient samples and assay development to the collaboration.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Dec
15
Sponsored by
UgenTec

Diverse components of the UC Davis campus have been mobilized to deploy HTP testing to provide a safe working environment and keep the pandemic under control.